Filter
360
Filtered Results: 360
Text search:
inactivated
vaccines
Featured
Recommendations
44
New Publications
105
Language
Document type
No document type
174
Guidelines
92
Studies & Reports
39
Manuals
20
Fact sheets
19
Strategic & Response Plan
7
Situation Updates
5
Training Material
3
Resource Platforms
1
Countries / Regions
India
11
Germany
11
Global
11
South Africa
10
Nigeria
8
Pakistan
8
Latin America and the Carribbean
7
Sierra Leone
6
Ethiopia
6
Philippines
6
Syria
6
Nepal
5
Afghanistan
5
Tanzania
5
Uganda
4
Kenya
4
Namibia
4
Ukraine
4
Chile
4
Rwanda
3
Ecuador
3
Myanmar / Burma
3
Yemen
3
Middle East and North Africa
3
Western and Central Europe
3
Africa
3
Russia
3
Liberia
2
Congo, Democratic Republic of
2
Zambia
2
Bangladesh
2
Malawi
2
Papua New Guinea
2
East and Southern Africa
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Venezuela
2
Niger
1
Zimbabwe
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
Gambia
1
China
1
Indonesia
1
Argentina
1
Peru
1
Brazil
1
North Macedonia
1
Colombia
1
Botswana
1
Bolivia
1
Libya
1
Lesotho
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
110
Clinical Guidelines
49
Women & Child Health
17
Key Resources
9
Public Health
8
Pharmacy & Technologies
7
Capacity Building
1
Toolboxes
COVID-19
82
Polio
38
Rapid Response
25
Ebola
16
TB
16
Pharmacy
15
Refugee
14
HIV
11
AMR
11
NTDs
11
Conflict
8
Cholera
7
Zika
5
Natural Hazards
4
Planetary Health
3
Mental Health
2
Specific Hazards
1
Global Health Education
1
Health Financing Toolbox
1
NCDs
1
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
3 February 2021
Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical guidance needed to develop a communication plan that ...
Update 2021; Immunization, Vaccines and Biologicals
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
Weekly epidemiological record/ Relevé épidémiologique hebdomadaire 4 AUGUST 2017, 92th YEAR / 4 AOÛT 2017, 417-436
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and highlights priority actions, targets and indicators that address the specific needs and challenges of...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
This document provides guidance on interventions to prevent vaccine-preventable disease outbreaks in the context of mass population movement resulting from the ongoing crisis in Ukraine.
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
